Medtronic Plc (MDT) Annual Income Statement

Annual · GAAP · USD millions
Access MDT quarterly income statements →
Reviewing income statement figures over time helps illustrate how Medtronic Plc generates earnings and manages operating expenses.
Annual Report, GAAP in USD millions
ITEM
(Apr 24 2026)
2026
(Apr 25 2025) (Apr 26 2024) (Apr 28 2023) (Apr 29 2022)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax36,364.00
Total Revenue36,364.00
Costs & Expenses
Cost of Goods and Services Sold12,721.00
Gross Profit0.00
Selling, Administration, Marketing11,784.00
Depreciation & Amortization2,958.00
Research and Development Expense (Excluding Acquired in Process Cost)2,873.00
Other operatinig exp. /-income0.00
Unusual Income/ -Expense113.00
Total operating costs including COS0.00
Operating income / -loss6,467.00
Interest Expense0.00
Interest Expense, Borrowings885.00
Net Interest (-)Expense / Income0.00
Sale of Business-57.00
Other loss/ -income0.00
Total costs & expenses0.00
Income & Taxes
Income / -loss before income taxes6,136.00
Income taxes expenses / -benefit1,299.00
Income after income taxes4,837.00
Net income / -loss of other equity0.00
Income / -loss from continuing operations4,837.00
Non-controlling interests37.00
Net income / -loss4,837.00
Income / -loss to shareholder0.00
EBIT6,136.00
EBITD6,962.00
EBITDA9,146.00
Earnings Per Share
Basic EPS (excl. extra items)3.75
Basic Net EPS3.75
Basic shares outstanding (Mill. of Units)1,281.80
Diluted Net EPS3.73
Diluted average shares (Mill. of Units)1,288.10
Dividend per share2.84
4 historic quarters locked

Sign in to unlock the full Medtronic Plc income statement history.

About Medtronic Plc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: June 18, 2026
  • Original filing: mdt-20260424.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.